Insider Transactions last 24 months for X4 Pharmaceuticals, Inc.  -  NSDQ: XFOR

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Craig Adam RExecutive Chairman10/23/2025APDirectCOM86,206$2.90$249,997.40376,087
Kirske DavidChief Financial Officer08/14/2025AADirectCOM193,254$0.00$0.00193,254
Craig Adam RExecutive Chairman08/14/2025AADirectCOM289,881$0.00$0.00289,881
Volpone JohnPresident08/14/2025AADirectCOM289,881$0.00$0.00289,881
Wyzga Michael SDirector06/09/2025AADirectCOM1,500$0.00$0.005,555
Mcgirr David W JDirector06/09/2025AADirectCOM1,500$0.00$0.004,722
Woods KeithDirector06/09/2025AADirectCOM1,500$0.00$0.006,000
Bridger GaryDirector06/09/2025AADirectCOM1,500$0.00$0.004,722
De Craecker FrancoiseDirector06/09/2025AADirectCOM1,500$0.00$0.004,722
Stewart MurrayDirector06/09/2025AADirectCOM1,500$0.00$0.007,883
Thoren Natasha FayChief Legal Officer05/20/2025AADirectCOM3,333$0.00$0.009,462
Baldry MarkChief Commercial Officer05/16/2025APDirectCOM1,032$2.48$2,561.4225,337
Dibiase MaryChief Operating Officer02/12/2025AADirectCOM650,000$0.00$0.001,140,980
Baldry MarkChief Commercial Officer02/12/2025AADirectCOM600,000$0.00$0.00729,173
Ragan PaulaPresident and CEO02/12/2025AADirectCOM2,250,000$0.00$0.003,337,386
Mostafa Adam S.Chief Financial Officer02/12/2025AADirectCOM850,000$0.00$0.00850,000
Arbet-Engels ChristopheChief Medical Officer02/12/2025AADirectCOM850,000$0.00$0.00864,207
Arbet-Engels ChristopheChief Medical Officer01/24/2025DSDirectCOM11,624$0.45$5,284.2714,207
Dibiase MaryChief Operating Officer01/24/2025DSDirectCOM22,258$0.45$10,094.00490,980
Baldry MarkChief Commercial Officer01/24/2025DSDirectCOM29,159$0.45$13,241.1094,123
Mostafa Adam S.Chief Financial Officer01/24/2025DSDirectCOM74,773$0.45$33,946.940
Ragan PaulaPresident and CEO01/24/2025DSDirectCOM76,473$0.45$34,718.741,087,386
Arbet-Engels ChristopheChief Medical Officer01/23/2025AADirectCOM25,831$0.00$0.0025,831
Dibiase MaryChief Operating Officer01/23/2025AADirectCOM61,178$0.00$0.00513,238
Baldry MarkChief Commercial Officer01/23/2025AADirectCOM74,773$0.00$0.00123,282
1   2  Next Last  You are at page 1 of 2 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel